Liver transplantation (LT) stays the only real curative treatment for close-stage liver disease as well as acute liver failure. While using the exponential rise in organ demand from customers as a result of raising incidence and prevalence of liver disorders, the need to conquer the availability and demandCardiac resynchronization therapy (CRT) has